|
Simon M, Gil-Gallardo LJ, Asuncion Iborra M, Carrilero B, Lopez MC, Romay-Barja M, Murcia L, Carmen Thomas M, Benito A, Segovia M. An observational longitudinal study to evaluate tools and strategies available for the diagnosis of Congenital Chagas Disease in a non-endemic country. Acta Trop. 2019 Nov;199:105127. doi: 10.1016/j.actatropica.2019.105127. Epub 2019 Aug 5. PubMed PMID: 31394076.
AÑO: 2019; IF: 2.555
|
31394076
|
Egui A, Thomas MC, Fernandez-Villegas A, Perez-Anton E, Gomez I, Carrilero B, Del Pozo A, Ceballos M, Andres-Leon E, Lopez-Ruz MA, Gainza E, Oquinena E, Segovia M, Lopez MC. A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e02436-18. doi: 10.1128/AAC.02436-18. Print 2019 Oct. PubMed PMID: 31358581; PubMed Central PMCID: PMC6761566.
AÑO: 2019; IF: 4.904
|
|
Murcia L, Simón M, Carrilero B, Roig M, Segovia M. Treatment of Infected Women of Childbearing Age Prevents Congenital Trypanosoma cruzi Infection by Eliminating the Parasitemia Detected by PCR. J Infect Dis. 2017 May 1;215(9):1452-1458. doi: 10.1093/infdis/jix087. PubMed PMID: 28201741.
AÑO: 2017; IF: 5.186
|
|
Egui A, Thomas MC, Carrilero B, Segovia M, Alonso C, Marañón C, López MC. Differential phenotypic and functional profiles of TcCA-2 -specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in Chagasic patients. PLoS One. 2015 Mar 27;10(3):e0122115. doi: 10.1371/journal.pone.0122115. PubMed PMID: 25816096; PubMed Central PMCID: PMC4376724.
AÑO: 2015; IF: 3.057
|
|
Fernández-Villegas A, Thomas MC, Carrilero B, Téllez C, Marañón C, Murcia L, Moralo S, Alonso C, Segovia M, López MC. The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country. Acta Trop. 2014 Dec;140:84-90. doi: 10.1016/j.actatropica.2014.08.006. PubMed PMID: 25149352.
AÑO: 2014; IF: 2.27
|